A sensitivity analysis which excluded people with diabetes who were taking oral glucose-lowering drugs, with or without insulin, or had missing information regarding glucose-lowering therapies, showed that the outcomes were essentially unchanged (Supplementary Table S1). This evidence concerns the gene INS and diabetes mellitus.